|
1）日本産科婦人科学会，日本病理学会，日本医学放射線学会ほか（編）：リンパ節の部位と名称．子宮頸癌取扱い規約，第3版，金原出版，東京，p9─12，2012
|
|
|
|
|
2）日本癌治療学会（編）：リンパ節の部位と名称．日本癌治療学会リンパ節規約，金原出版，東京，p14─16，2002
|
|
|
|
|
|
3)Berek JS:Berek & Novak's Gynecology, ed by Berek JS, Lippincott Williams&Wilkins, Philadelphia, p1316, 2012
|
|
|
|
|
|
4)Sevin BU, Nadji M, Averette HE et al:Microinvasive carcinoma of the cervix. Cancer 70:2121-2128, 1992
|
|
|
|
|
5)Elliott P, Coppleson M, Russell P et al:Early invasive(FIGO stage IA)carcinoma of the cervix;a clinico-pathologic study of 476 cases. Int J Gynecol Cancer 10:42-52, 2000
|
|
|
|
|
|
6)van Meurs H, Visser O, Buist MR et al:Frequency of pelvic lymph node metastases and parametrial involvement in stage IA2 cervical cancer;a population-based study and literature review. Int J Gynecol Cancer 19:21-26, 2009
|
|
|
|
|
|
7）婦人科腫瘍委員会報告：2011年度子宮頸癌患者年報．日産婦会誌64：2340─2353，2012
|
|
|
|
|
|
8)Sakuragi N, Satoh C, Takeda N et al:Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stage ⅠB, ⅡA, and ⅡB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547-1554, 1999
|
|
|
|
|
|
9)Benedetti-Panici P, Maneschi P, Scambia G et al:Lymphatic spread of cervical cancer;an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62:19-24, 1996
|
|
|
|
|
|
10)Morice P, Castaigne D, Pautier P et al:Interest of pelvic and paraaortic lymphadenectomy in patients with stage ⅠB and Ⅱ cervical carcinoma. Gynecol Oncol 73:106-110, 1999
|
|
|
|
|
|
11)van de Lande J, Davelaar EM, von Mensdorff-Pouilly S et al:Sentinel lymph node detection in early stage uterine cervix carcinoma;a systematic review. Gynecol Oncol 106:604-613, 2007
|
|
|
|
|
|
12)Altgassen C, Hertel H, Brandstadt A et al:AGO study group;multicenter validation study of the sentinel lymph node concept in cervical cancer;AGO Study Group. J Clin Oncol 26:2943-2951, 2008
|
|
|
|
|
|
13）婦人科腫瘍委員会報告（第53回治療年報）．日産婦誌65：1167─1185，2013
|
|
|
|
|
|
14)Pecorelli S:26th Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 95[Suppl 1]:S105-S143, 2006
|
|
|
|
|
|
15)Watanabe M, Aoki Y, Kase H et al:Low risk endometrial cancer;a study of pelvic lymph node metastasis. Int J Gynecol Cancer 13:38-41, 2003
|
|
|
|
|
|
16)Goff BA, Kato D, Schmidt RA et al:Uterine papillary serous carcinoma;patterns of metastatic spread. Gynecol Oncol 54:264-268, 1994
|
|
|
|
|
|
17)Trimble EL, Kosary C, Park RC:Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340-343, 1998
|
|
|
|
|
|
18)Cragun JM, Havrilesky LJ, Calingaert B et al:Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668-3675, 2005
|
|
|
|
|
|
19)Candiani GB, Belloni C, Maggi R et al:Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I. Gynecol Oncol 37:6-8, 1990
|
|
|
|
|
|
20)Sartori E, Gadducci A, Landoni F et al:Clinical behavior of 203 stageⅡendometrial cancer cases;the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11:430-437, 2001
|
|
|
|
|
|
21)ASTEC study group, Kitchener H, Swart AM et al:Efficacy of systematic pelvic lymphadenectomy in endometrial cancer(MRCASTEC trial);a randomised study. Lancet 373:125-136, 2009
|
|
|
|
|
|
22)Benedetti-Panici P, Basile S, Maneschi F et al:Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma;randomized clinical trial. J Natl Cancer Inst 100:1707-1716, 2008
|
|
|
|
|
|
23)Naumann RW:The role of lymphadenectomy in endometrial cancer;was the ASTEC trial doomed by design and are we destined to repeat that mistake？ Gynecol Oncol 126:5-11, 2012
|
|
|
|
|
|
24)Mariani A, Webb MJ, Galli L et al:Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76:348-356, 2000
|
|
|
|
|
|
25)Onda T, Yoshikawa H, Mizutani K et al:Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 75:1836-1841, 1997
|
|
|
|
|
|
26)Ayhan A, Tuncer R, Tuncer ZS et al:Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer(a multivariate analysis of 183 cases). Int J Gynecol Cancer 4:306-309, 1994
|
|
|
|
|
|
27）日本婦人科腫瘍学会（編）：子宮体癌の術後再発リスク分類．子宮体がん治療ガイドライン，2009年版，金原出版，東京，p15， 2009
|
|
|
|
|
|
28)Todo Y, Kato H, Kaneuchi M et al:Survival effect of para-aortic lymphadenectomy in endometrial cancer(SEPAL study);a retrospective cohort analysis. Lancet 375:1165-1172, 2010
|
|
|
|
|
|
29)Nishiya M, Sakuragi N, Hareyama H et al:Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging. Int J Cancer 79:521-552, 1998
|
|
|
|
|
|
30)Lo KW, Cheung TH, Yu MY et al:The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13:863-869, 2003
|
|
|
|
|
|
31)Chan JK, Cheung MK, Huh WK et al:Therapeutic role of lymph node resection in endometrioid corpus cancer;a study of 12,333 patients. Cancer 107:1823-1830, 2006
|
|
|
|
|
|
32)Milam MR, Java J, Walker JL et al:Gynecologic Oncology Group;nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 119:286-292, 2012
|
|
|
|
|
|
33)Bar-Am A, Ron IG, Kuperminc M et al:The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma;second thoughts. Acta Obstet Gynecol Scand 77:347-350, 1998
|
|
|
|
|
|
34)Lopes LA, Nicolau SM, Baracat FF et al:Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer 17:1113-1117, 2007
|
|
|
|
|
|
35)Frumovitz M, Bodurka DC, Broaddus RR et al:Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104:100-103, 2007
|
|
|
|
|
|
36)Petru E, Lahousen M, Tamussino K et al:Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170:656-662, 1994
|
|
|
|
|
|
37)Panici PB, Maggioni A, Hacker N et al:Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer;a randomized clinical trial. J Natl Cancer Inst 97:560-566, 2005
|
|
|
|
|
|
38)Pereira A, Magrina JF, Rey V et al:Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol 105:604-608, 2007
|
|
|
|
|
|
39)Chan JK, Munro EG, Cheung MK et al:Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109:12-19, 2007
|
|
|
|
|
|
40)Aletti GD, Dowdy S, Podratz KC et al:Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 195:1862-1868, 2006
|
|
|
|
|
|
41)du Bois A, Reuss A, Harter P et al:Potential role of lymphadenectomy in advanced ovarian cancer;a combined exploratory analysis of three prospectively randomized phaseIII multicenter trials. J Clin Oncol 28:1733-1739, 2010
|
|
|
|
|